Prostate Cancer - Results from #620

Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis. August 20, 2024

Evaluation of prostate cancer detection using micro-ultrasound versus MRI through co-registration to whole-mount pathology. August 20, 2024

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate. August 19, 2024

Evaluating the added value of concurrent contrast-enhanced diagnostic CT for PSMA-PET/CT Interpretation. August 19, 2024

How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden? August 19, 2024

Understanding and Addressing Prostate Cancer Disparities in Diagnosis, Treatment, and Outcomes Among Black Men. August 19, 2024

Using gene and gene-set association tests to identify lethal prostate cancer genes. August 19, 2024

Validation of candidate protein biomarkers previously identified by genetic instruments for prostate cancer risk: A prospective cohort analysis of directly measured protein levels in the ARIC study. August 19, 2024

Contemporary treatment standards and trends of systemic therapy in metastatic hormone-sensitive prostate cancer-implementing study data in clinical practice. August 16, 2024

Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer. August 16, 2024

Evaluating the Efficacy of ChatGPT as a Patient Education Tool in Prostate Cancer: Multimetric Assessment. August 16, 2024

Standardized template for clinical reporting of PSMA PET/CT scans. August 16, 2024

Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial. August 16, 2024

Preoperative Prostate Magnetic Resonance Imaging-based Anatomical Predictors of Early Urinary Continence Following Single-port Transvesical Robot-assisted Radical Prostatectomy. August 16, 2024

NICE Recommends ORGOVYX® (Relugolix) as the First Oral ADT Treatment for Hormone Sensitive Prostate Cancer in England August 15, 2024

Impact of the diagnostic label for a low-risk prostate lesion: protocol for two online factorial randomised experiments. August 15, 2024

Abiraterone Acetate Versus Enzalutamide Against Chemo-Naïve Castration-Resistant Prostate Cancer With Full-Dose Induction. August 15, 2024

Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population-based estimates August 14, 2024

Technical and Ethical Considerations in Telesurgery August 14, 2024

A contemporary review: mpMRI in prostate cancer screening and diagnosis. August 14, 2024

Page 32 of 1447